Morphological disease progression of combined pulmonary fibrosis and emphysema: Comparison with emphysema alone and pulmonary fibrosis alone

Journal of Computer Assisted Tomography

Volumn 39, Issue 2, 2015, Pages 153-159

  Matsuoka, Shin ^a   Yamashiro, Tsuneo ^a,b   Matsushita, Shoichiro ^a   Fujikawa, Atsuko ^a   Kotoku, Akiyuki ^a   Yagihashi, Kunihiro ^a   Kurihara, Yasuyuki ^c   Nakajima, Yasuo ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

Author keywords

combined pulmonary fibrosis and emphysema; computed tomography; CT quantification; densitometry; disease progression

Indexed keywords

COMBINED PULMONARY FIBROSE AND EMPHYSEMA; COMPUTED TOMOGRAPHY; CT QUANTIFICATION; DENSITOMETRY; DISEASE PROGRESSION; HOUNSFIELD UNITS; MORPHOLOGICAL CHANGES; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; QUANTITATIVE COMPUTED TOMOGRAPHIES;

COMPUTERIZED TOMOGRAPHY;

BRONCHODILATING AGENT; CORTICOSTEROID;

AGED; ARTICLE; ATTENUATION; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE COURSE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG EMPHYSEMA; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ERROR; MEDICAL RECORD REVIEW; MORPHOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; SMOKING; COMPARATIVE STUDY; COMPLICATION; PATHOLOGY; RADIOGRAPHY;

AGED; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84925863209     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0000000000000184     Document Type: Article

References (24)

1. Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct under recognised entity. Eur Respir J. 2005;26: 586-593.
2. Wright JL, Tazelaar HD, Churg A. Fibrosis with emphysema. Histopathology. 2011;58:517-524.
3. Cottin V, Nunes H, Mouthon L, et al. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum. 2011; 63:295-304.
4. Sakai F, Tominaga J, Kaga A, et al. Imaging diagnosis of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema). Pulm Med. 2012;2012:816541.
5. Inomata M, Ikushima S, Awano N, et al. An autopsy study of combined pulmonary fibrosis and emphysema: correlations among clinical, radiological, and pathological features. BMC Pulm Med. 2014;14:104.
6. Kitaguchi Y, Fujimoto K, Hanaoka M, et al. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology. 2010;15: 265-271.
7. Grubstein A, Bendayan D, Schactman I, et al. Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature. Respir Med. 2005;99:948-954.
8. Mura M, Zompatori M, Pacilli AM, et al. The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis. Respir Care. 2006;51:257-265.
9. Jankowich MD, Polsky M, Klein M, et al. Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration. 2008;75:411-417.
10. Mejia M, Carrillo G, Rojas-Serrano J, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest. 2009;136:10-15.
11. Cottin V, Le Pavec J, Prevot G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J. 2010;35:105-111.
12. Usui K, Tanai C, Tanaka Y, et al. The prevalence of pulmonary fibrosis combined with emphysema in patientswith lung cancer. Respirology. 2011; 16:326-331.
13. Akagi T, Matsumoto T, Harada T, et al. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir Med. 2009;103:1209-1215.
14. Kitaguchi Y, Fujimoto K, Hayashi R, et al. Annual changes in pulmonary function in combined pulmonary fibrosis and emphysema: over a 5-year follow-up. Respir Med. 2013;107:1986-1992.
15. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183: 788-824.
16. Shin KE, Chung MJ, Jung MP, et al. Quantitative computed tomographic indexes in diffuse interstitial lung disease: correlation with physiologic tests and computed tomography visual scores. J Comput Assist Tomogr. 2011; 35:266-271.
17. Best AC, Meng J, Lynch AM, et al. Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality. Radiology. 2008;246:935-940.
18. Kawabata Y, Hoshi E, Murai K, et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology. 2008;53: 707-714.
19. Cardoso WV, Sekhon HS, Hyde DM, et al. Collagen and elastin in human pulmonary emphysema. Am Rev Respir Dis. 1993;147:975-981.
20. Lang MR, Fiaux GW, Gillooly M, et al. Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax. 1994;49: 319-326.
21. Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J. 2005;25:552-563.
22. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med. 1990;84:365-369.
23. Rogliani P,MuraM,Mattia P, et al. HRCTand histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema. Respir Med. 2008;102:1753-1761.
24. Chemla D, Castelain V, Herve P, et al. Haemodynamic evaluation of pulmonary hypertension. Eur Respir J. 2002;20:1314-1331.